Comparison of Benefit-to-Burden Ratios for Stool-Based Colorectal Cancer Screening Tests in the U.S.: A Decision Analytical Modeling Approach
Performance advantages associated with triennial next-generation multitarget stool DNA from ages 45 to 75 years provided the best benefit to burden of the age- and interval-recommended stool-based screening strategies.
Authors
- John B. Kisiel (ORCID: https://orcid.org/0000-0002-3840-5324)
- Paul J. Limburg (ORCID: https://orcid.org/0000-0002-2428-5675)
- Michael M. Dore (ORCID: https://orcid.org/0000-0001-9074-9872)
- Vahab Vahdat (ORCID: https://orcid.org/0000-0001-7831-7567)
- Ahmet Burak Ozbay (ORCID: https://orcid.org/0000-0002-8624-6313)
- A. Mark Fendrick (ORCID: https://orcid.org/0000-0002-7734-6742)
- Chris Estes (ORCID: https://orcid.org/0000-0002-2367-6535)
- Derek W. Ebner
Institutions
- Mayo Clinic (US)
- Duke University (US)
- University of Michigan (US)
- WinnMed (US)
- Exact Sciences (United States) (US)
Publication Details
- Journal
- AJPM Focus
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1016/j.focus.2025.100429
- Citations
- 1
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 1.05